| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 2e-06 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.007 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.001 |